Vodič za dijagnostikovanje i lečenje raka grlića materice - Institut za ...

55. Amit A, Beck D, Lowenstein L, Lavie O, Bar Shalom R, Kedar Z, et al. The role of
hybrid PET/CT in the evaluation of patients with cervical cancer. Gynecol Oncol
2006;100:65-9.
56. Loft A, Berthelsen AK, Roed H, Ottosen C, Lundvall L, Knudsen J, et al. The
diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective
study. Gynecol Oncol 2007;106(1):29-34.
57. Hricak H, Yu KK. Radiology in invasive cervical cancer. AJR Am J Roentgenol
1996;167(5):1101-1118
58. Fischerova D. Ultrasound scanning of the pelvis and abdomen for staging of
gynecological tumors: a review. Ultrasound Obstet Gynecol, 2011; 38:246.266
59. Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic
helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in
cervical carcinoma. AJR Am J Roentgenol, 2000;175:759-66.
60. Patel CN, Nayir SA, Khan Y et al. 18F-FDG PET/CT of cervical carcinoma. AJR. Am
J Roentgenol, 2011; 196: 1225-1233
61. UICC International Union Against Cancer. TNM Classification of Malignant Tumours.
Seventh ed. Sobin L, Gospodarowicz M, Wittekind C, editor. New York: Wiley-
Blackwell; 2009
62. Colombo N, Carinelli S, Colombo Am Marini C, Rollo D, Sessa C on behalf of the
ESMO Guidelines Working Group. Cervical cancer. ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow/up. Annals of Oncology, 2012; 23
(supplement 7): vii27-vii32
63. Elliott P, Coppleson M, Russel P: Early invasive (FIGO stage Ia) carcinoma of the
cervix: a clinico-pathologic study of 476 cases. Int J Gynecol Cancer, 2000; 10: 42-52
64. Girardi F, Burghardt E, Pickel H.: Small FIGO Stage IB Cervical Cancer. Gynecol
Oncol 1994: 55, 427-432
65. Vergote I, Vlayen J, Robays J, Stordeur S, Stemkens D, Smit Y, Bourgain C, De
Grève J, Kridelka F, Scalliet P, Simon P, Stroobants S, Van Dam P, Van Limbergen
E, Villeirs G. Een nationale praktijkrichtlijn voor de aanpak van cervixkanker. Good
Clinical Practice (GCP). Brussel: Federaal Kenniscentrum voor de Gezondheidszorg
(KCE). 2011. KCE Reports vol A. D/2011/10.273/69
66. Landoni F, Maneo A, Colombo A et al. Randomized study of radical surgery versus
radiotherapy for stage Ib-IIa cervical cancer. Lancet, 1997; 350: 535–40
67. Spoozak L, Lewin SN, Burke WM, Deutsch I, Sun X, Herzog TJ, Wright JD.
Microinvasive adenocarcinoma of the cervix. Am J Obstet Gynecol, 2012; 80.e1-6
68. Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman LD, Cliby WA.
Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by
treatment type. Obstet Gynecol, 2010; 116: 1150-70
69. Yahata T, Nishino K, Kashima K, Sekine M, Fujita K, Sasagawa M, Honma S,
Kodama S, Tanaka K. Conservative treatment of stage Ia1 adenocarcinoma of the
uterine cervix with a long-term follow-up. Int J Gynecol Cancer, 2012; 20: 1063-6
70. Baalbergen A, Smedts F, Helmerhorst TJ. Conservative therapy in microinvasive
adenocarcinoma of the uterine cervix is justified: an analysis of 59 cases and a
review of the literature. Int J Gynecol Cancer, 2011; 21: 1640-5
71. Piver S, Rtledge F, Smith JP.Five classes of extended hysterectomy for women with
cervical cancer. Obstet Gynecol, 1974;44:265
72. Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickirsh G et al. How
important is removal of the parametrium at surgery for carcinoma of the cervix?
Gynecol Oncol, 2002; 84: 145-9
73. Stegman M, Louwen M, van der Velden J, ten Kate FJ, den Bakker MA, Burger CW
et al. The incidence of parametrial involvement in select patients with early cervix
xancer is too low to justify parametrectomy. Gynecol Oncol, 2007; 105: 475-80
74. Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F et al. Utility of
parametrectomy for early stage cervical cancer treated with radical hysterectomy.
Cancer, 2007; 110: 1281-677
71